4//SEC Filing
REIN HARRY T 4
Accession 0001104659-08-020020
CIK 0001113784other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 6:53 PM ET
Size
28.5 KB
Accession
0001104659-08-020020
Insider Transaction Report
Form 4
CARDIONET INCBEAT
REIN HARRY T
Director
Transactions
- Conversion
Mandatorily Convertible Preferred Stock
2008-03-25−1,064→ 0 total(indirect: See Footnote)→ Common Stock (71,164 underlying) - Conversion
Warrants to Purchase Series D-1 Convertible Preferred Stock
2008-03-25−91,632→ 0 total(indirect: See Footnote)→ Common Stock (27,996 underlying) - Conversion
Common Stock
2008-03-25$3.50/sh+27,996$97,986→ 627,597 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2008-03-25−857,143→ 0 total(indirect: See Footnote)→ Common Stock (428,571 underlying) - Conversion
Common Stock
2008-03-25+428,571→ 428,571 total(indirect: See Footnote) - Conversion
Common Stock
2008-03-25+99,866→ 528,437 total(indirect: See Footnote) - Conversion
Common Stock
2008-03-25+71,164→ 599,601 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2008-03-25−199,732→ 0 total(indirect: See Footnote)→ Common Stock (99,866 underlying)
Footnotes (7)
- [F1]Each 2 shares of Series C Convertible Preferred Stock converted into 1 share of the Issuer's common stock upon the closing of the initial public offering for no additional consideration and had no expiration date.
- [F2]By Foundation Medical Partners LP. The voting and disposition of the shares held by Foundation Medical Partners LP is determined by Andrew D. Firlik, Lee R. Wrubel and Harry T. Rein as the general partners of Foundation Medical Partners LP. Messrs. Firlik, Wrubel and Rein have shared voting and investment power over the shares held by Foundation Medical Partners LP. Messrs. Firlik, Wrubel and Rein disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein.
- [F3]Each 2 shares of Series D Convertible Preferred Stock converted into 1 share of the Issuer's common stock upon the closing of the initial public offering for no additional consideration and had no expiration date.
- [F4]Each share of Mandatorily Convertible Preferred Stock converted into 66.88 shares of the Issuer's common stock upon the closing of the initial public offering for no additional consideration and had no expiration date.
- [F5]Warrants became exercisable on March 8, 2007.
- [F6]Warrants to purchase Series D-1 Convertible Preferred were automatically net exercised immediately prior to the closing of the Issuer's initial public offering. Each 2 shares of Series D-1 Convertible Preferred Stock converted into 1 share of the Issuer's common stock upon the closing of the initial public offering for no additional consideration and had no expiration date.
- [F7]Warrants were net exercised resulting in fewer shares being issued than if the exercise price had been paid for with cash.
Documents
Issuer
CARDIONET INC
CIK 0001113784
Entity typeother
IncorporatedCT
Related Parties
1- filerCIK 0001012849
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 6:53 PM ET
- Size
- 28.5 KB